We are live on ! Find out more
BCI

Bain Capital Investors Portfolio holdings

AUM $3.27B
1-Year Est. Return 3.23%
This Fund
S&P 500
This Quarter Est. Return
+42.55%
1 Year Est. Return
+3.23%
3 Year Est. Return
+87.05%
5 Year Est. Return
+97.69%
10 Year Est. Return
+813.76%
AUM
$2.64B
AUM Growth
+$1.42B
Cap. Flow
+$793M
Cap. Flow %
30.04%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$788M
2
ADV icon
Advantage Solutions
ADV
+$30.4M

Top Sells

Rank Stock Value
1
VRTV
VERITIV CORPORATION
VRTV
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 71.36%
2 Consumer Discretionary 26.03%
3 Communication Services 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CERE
1
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.01B 38.09%
+60,632,356
New +$788M
SGRY icon
2
Surgery Partners
SGRY
$2.01B
$767M 29.08%
26,455,651
– –
MIK
3
DELISTED
Michaels Stores, Inc
MIK
$687M 26.03%
52,798,929
– –
IQV icon
4
IQVIA
IQV
$39.8B
$111M 4.19%
617,484
– –
ADV icon
5
Advantage Solutions
ADV
$399M
$38.1M 1.44%
+115,600
New +$30.4M
VRTV
6
DELISTED
VERITIV CORPORATION
VRTV
$28.8M 1.09%
1,383,840
-1,400,000
-50% -$25.2M
ATTO
7
DELISTED
Atento S.A.
ATTO
$2.13M 0.08%
156,574
– –

Similar funds

AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return

Bain Capital Investors's Q4 2020 Portfolio in Review

As of Q4 2020, Bain Capital Investors held 7 positions worth $2.64B, up 116% from $1.22B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bain Capital Investors deployed $793M of net new capital in Q4 2020, opening 2 new positions. Its largest new stake was Cerevel Therapeutics Holdings, Inc. Common Stock: 60,632,356 shares worth $1.01B.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 55% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was VERITIV CORPORATION, an estimated $25.2M trimmed.

  • Bain Capital Investors's largest Q4 2020 buy was Cerevel Therapeutics Holdings, Inc. Common Stock: 60,632,356 shares worth $1.01B.
  • Bain Capital Investors's biggest Q4 2020 reduction was VERITIV CORPORATION, cutting an estimated $25.2M.
  • Bain Capital Investors's ten largest holdings make up 100% of its $2.64B portfolio in Q4 2020.
  • Bain Capital Investors opened 2 new positions and closed 0 in Q4 2020.
  • Bain Capital Investors's portfolio value rose 116% quarter-over-quarter to $2.64B.

Based on Bain Capital Investors's 13F filing for Q4 2020, filed 16 Feb 2021.